Moderna soars 6% as it begins vaccine testing in babies and children

A person receives the Moderna COVID-19 vaccine at the East Boston Neighborhood Health Center (EBNHC) in Boston, Massachusetts on December 24, 2020.
Joseph Prezioso / AFP via Getty Images
Shares of Moderna rose 6.5% on Tuesday after the drugmaker announced it will begin testing its COVID-19 vaccine on children ages six months to 11 years.
Currently, Moderna's vaccines are approved only for adults 18 years and older.
While children have largely been spared from the virus, they still can become in